Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyClinicalTrials.gov · 2026-09-11Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting SystemmedRxiv · 2026-09-10A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2026-09-04Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot StudyClinicalTrials.gov · 2026-09-03High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite TrialClinicalTrials.gov · 2026-09-02Psilocybin-Assisted Psychotherapy for Posttraumatic Stress Disorder in Military Veterans: A Pilot Feasibility StudyClinicalTrials.gov · 2026-08-28Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Psilocybin/Psilocin from Psilocybe cubensis (Magic Mushroom) in Treatment-Resistant Depression.European journal of drug metabolism and pharmacokinetics · 2026-08-28Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)ClinicalTrials.gov · 2026-08-13A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.Psychology and psychotherapy · 2026-08-10Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseClinicalTrials.gov · 2026-08-07Cardiovascular safety of psilocybin in psychiatric practice: a narrative reviewEuropean Journal of Clinical Pharmacology · 2026-08-01Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for Post-Traumatic Stress DisorderClinicalTrials.gov · 2026-07-30No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosisFrontiers in Public Health · 2026-07-20Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in miceMolecular Psychiatry · 2026-07-07The Australia story: Current status and future challenges for the clinical applications of psychedelics.British journal of pharmacology · 2026-07-01Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”PLOS One · 2026-06-30Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and EfficacyClinicalTrials.gov · 2026-06-22Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic ReviewCNS Drugs · 2026-06-14Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional surveymedRxiv · 2026-06-01Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized painJournal of clinical and translational science · 2026-05-20356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-05-01A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back PainClinicalTrials.gov · 2026-04-29Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders.Trends in psychiatry and psychotherapy · 2026-04-25Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted PsychotherapyClinicalTrials.gov · 2026-04-22Serotonergic Polypharmacology of 2-Halogenated Tryptamines.bioRxiv: the preprint server for biology · 2026-04-21Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-13Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administrationNature Communications · 2026-04-10Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory DepressionClinicalTrials.gov · 2026-03-27Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging TrialClinicalTrials.gov · 2026-03-24“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practiceDrugs Education Prevention and Policy · 2026-03-22Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot StudyClinicalTrials.gov · 2026-03-18Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapyJournal of Affective Disorders · 2026-03-01The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?Psychiatric Research and Clinical Practice · 2026-03-01Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH StudyClinicalTrials.gov · 2026-02-17Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies.Pharmaceuticals (Basel, Switzerland) · 2026-02-14Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).Professional Psychology Research and Practice · 2026-02-01Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.The Australian and New Zealand journal of psychiatry · 2026-02-01Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted TherapyPsychedelic Medicine · 2026-01-12A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin.Human psychopharmacology · 2026-01-01New Antidepressant Development in the Treatment of Depression.Advances in experimental medicine and biology · 2026-01-01Systematic study of (, ) sensu lato and psilocybin-producing traits of species from China.IMA fungus · 2026-01-01The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal IdeationClinicalTrials.gov · 2025-12-24Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?Trends in psychiatry and psychotherapy · 2025-12-17Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility StudyClinicalTrials.gov · 2025-12-04Psychedelics for the Treatment of Substance Use DisordersSUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · 2025-12-01Three Cases of Depersonalization/Derealization Disorder Related to the Use of Classic PsychedelicsSUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · 2025-12-01Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in SwitzerlandmedRxiv · 2025-12-01Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.ClinicalTrials.gov · 2025-11-19Emerging mechanisms of psilocybin-induced neuroplasticity.Trends in pharmacological sciences · 2025-11-01Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine Exposure.Cureus · 2025-11-01A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?ClinicalTrials.gov · 2025-10-29Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High Gamma Functional Connectivity in Rats.bioRxiv: the preprint server for biology · 2025-10-14Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.Psychopharmacology · 2025-10-01Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.Psychopharmacology · 2025-10-01Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.Psychopharmacology · 2025-10-01The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.Molecular psychiatry · 2025-10-01Trauma under psychedelics: how psychoactive substances impact trauma processingWorld Psychiatry · 2025-09-15Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics · 2025-07-31Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation RetreatmedRxiv · 2025-07-30Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.Brain and behavior · 2025-07-01Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.Scientific data · 2025-06-18Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.Translational psychiatry · 2025-06-14Psilocybin With Intracranial Neural SensingClinicalTrials.gov · 2025-06-06Psilocybin's acute and persistent brain effects: a precision imaging drug trial.Scientific data · 2025-06-05In vitro assessment of psilocin for CYP-dependent drug-drug interaction potential using rapid luminescent assaysDrug Metabolism and Pharmacokinetics · 2025-06-01Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical PopulationmedRxiv · 2025-05-29Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23Identifying Three Psilocybin Use Patterns by Frequency and Quantity.Journal of studies on alcohol and drugs · 2025-05-01Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi StudyInternational Journal of Multiple Research Approaches · 2025-04-30Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.BMJ open · 2025-04-15The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingClinicalTrials.gov · 2025-04-14458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene ExpressionBiological Psychiatry · 2025-04-0958. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-09Psilocybin-assisted Interpersonal Therapy for DepressionClinicalTrials.gov · 2025-04-09The compulsive eating paradigm: can psychedelics help in treating obesity?Journal of eating disorders · 2025-04-07A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-04-01Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation.Psychopharmacology · 2025-04-01A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-04-01Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex.Translational psychiatry · 2025-03-25Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020.Journal of psychoactive drugs · 2025-03-03Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.Molecular psychiatry · 2025-03-01Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online samplePsyArXiv · 2025-02-28The safety of psilocybin-assisted psychotherapy: A systematic review.The Australian and New Zealand journal of psychiatry · 2025-02-01A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major DepressionClinicalTrials.gov · 2025-01-20Molecular Phylogeny and Morphology Reveal Four New Species of (Bolbitiaceae, Agaricales) from the Qinghai-Xizang Plateau, China.Journal of fungi (Basel, Switzerland) · 2025-01-07Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.Clinical pharmacology and therapeutics · 2025-01-01Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.Clinical neuropharmacology · 2025-01-01Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.Frontiers in pharmacology · 2025-01-01Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care.Palliative medicine reports · 2025-01-01Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health NurseSaudi Journal of Medicine and Public Health · 2024-12-31Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyClinicalTrials.gov · 2024-12-04The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.CNS spectrums · 2024-12-01Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex.The European journal of neuroscience · 2024-11-01Does psilocybin reduce symptoms of depression in adults with major depressive disorder or life-threatening cancer?Evidence-Based Practice · 2024-10-09A psilocybin haven: the use of comparison to legitimate transgression at a psychedelic retreatDrugs Education Prevention and Policy · 2024-10-09Artificial intelligence and psychedelic medicine.Annals of the New York Academy of Sciences · 2024-10-01What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study.Palliative & supportive care · 2024-10-01Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent mannermedRxiv · 2024-09-11Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label StudyResearch Square · 2024-08-23An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)ClinicalTrials.gov · 2024-08-09Psilocybin desynchronizes the human brain.Nature · 2024-08-01Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global HealthcareTrends in Medical Research · 2024-06-28Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectanciesPsyArXiv · 2024-06-10Structural pharmacology and therapeutic potential of 5-methoxytryptamines.Nature · 2024-06-01From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream MedicineEuropean Journal of Arts Humanities and Social Sciences · 2024-05-01Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01Genetic regulation of L-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis.Fungal biology and biotechnology · 2024-04-25Do undergraduates’ views of psychedelics relate to the context for psychedelic use?PsyArXiv · 2024-04-24A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventionsJournal of Psychedelic Studies · 2024-04-02Inhibition of cytochrome P450 3A4 enzyme activity by alkaloid psilocin from magic mushrooms: potential for drug interactionsDrug Metabolism and Pharmacokinetics · 2024-04-01Five New Species of from Xizang Autonomous Region of China and Surrounding Areas.Journal of fungi (Basel, Switzerland) · 2024-03-18Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08Psilocybin induces dose-dependent changes in functional network organization in rat cortex.bioRxiv: the preprint server for biology · 2024-02-15Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.Scientific reports · 2024-02-07Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.Palliative medicine · 2024-02-01How should psychotherapy proceed when adjoined with psychedelics?World Psychiatry · 2024-01-12Drug-drug interactions involving classic psychedelics: A systematic review.Journal of psychopharmacology (Oxford, England) · 2024-01-01Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.Journal of addiction psychiatry · 2024-01-01Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain.Current biology: CB · 2023-12-18Beyond the 5-HT Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2023-11-08A "Magic Mushroom" Multi-Product Sesquiterpene Synthase.Chembiochem: a European journal of chemical biology · 2023-11-02An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations.The American journal of hospice & palliative care · 2023-11-01The Psychedelic Social Club: a regulatory concept for people who use psychedelics?Drugs Education Prevention and Policy · 2023-10-30Extended difficulties following the use of psychedelic drugs: A mixed methods studyPLoS ONE · 2023-10-23Is psilocybin effective for treatment of depression?Evidence-Based Practice · 2023-10-19Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.Scientific reports · 2023-10-14CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANSIBRO Neuroscience Reports · 2023-10-01The psychedelic experience and treatment-resistant depressionWorld Psychiatry · 2023-09-15Intravenous psilocybin administration attenuates mechanical hypersensitivity in a rat model of chronic painbioRxiv · 2023-08-28Psilocybin desynchronizes brain networks.medRxiv: the preprint server for health sciences · 2023-08-24A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin PharmacokineticsClinicalTrials.gov · 2023-08-15The molecular basis of the antidepressant action of the magic mushroom extract, psilocinBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2023-07-01Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic reviewmedRxiv · 2023-06-01Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.Psychedelic medicine (New Rochelle, N.Y.) · 2023-06-01Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disordersbioRxiv · 2023-05-18The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24Default Mode Network Modulation by Psychedelics: A Systematic Review.The international journal of neuropsychopharmacology · 2023-03-22Novel antidepressant drugs: Beyond monoamine targets.CNS spectrums · 2023-02-01Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.International journal of environmental research and public health · 2023-01-19Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trialJournal of Psychedelic Studies · 2023-01-18Empirically validated theoretical analysis of visual-spatial perception under change of nervous system arousal.Frontiers in computational neuroscience · 2023-01-01Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review.Frontiers in psychiatry · 2023-01-01Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.Frontiers in psychiatry · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.ClinicalTrials.gov · 2022-10-25Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)Journal of Anesthesiology and Pain Therapy · 2022-10-03Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.Current psychiatry reports · 2022-10-01Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.International journal of molecular sciences · 2022-09-28Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Neural mechanisms of psychedelic visual imagerymedRxiv · 2022-09-09Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.International journal of environmental research and public health · 2022-05-29Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.Substance abuse treatment, prevention, and policy · 2022-05-14Standards Without Labs: Drug Development in the Psychedelic UndergroundCitizen Science Theory and Practice · 2022-01-01Psychedelic medicines for mood disorders: current evidence and clinical considerations.Current opinion in psychiatry · 2022-01-013,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.Frontiers in psychiatry · 2022-01-01Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.The Australian and New Zealand journal of psychiatry · 2021-12-01Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.Cerebral cortex (New York, N.Y.: 1991) · 2021-11-23Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.International journal of molecular sciences · 2021-10-02Effects of psilocybin-assisted therapy on treatment-resistant depressionEuropean psychiatry: the journal of the Association of European Psychiatrists · 2021-08-13The Potential Role of Serotonergic Hallucinogens in Depression Treatment.Life (Basel, Switzerland) · 2021-07-29The need for publicly funded research on therapeutic use of psychedelic drugsWorld Psychiatry · 2021-05-18Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatmentDrugs Education Prevention and Policy · 2021-04-29Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.Molecules (Basel, Switzerland) · 2021-04-22Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.Psychopharmacology · 2021-02-01People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.Drugs (Abingdon, England) · 2021-01-01Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.Frontiers in psychiatry · 2021-01-01Cannabis as entheogen: survey and interview data on the spiritual use of cannabis.Journal of cannabis research · 2020-09-22Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.Biological psychiatry · 2020-07-15Emotions and brain function are altered up to one month after a single high dose of psilocybin.Scientific reports · 2020-02-10An Improved, Practical, and Scalable Five-Step Synthesis of PsilocybinSynthesis · 2020-01-08Psilocybin induces aberrant prediction error processing for tactile mismatch responsesEuropean Neuropsychopharmacology · 2019-01-01TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT receptor pharmacological tool, or none of the above?Neuropharmacology · 2018-11-01Serotonin, psychedelics and psychiatryWorld Psychiatry · 2018-09-07[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].L'Encephale · 2017-08-01LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in pharmacology · 2017-01-01Psilocybin in end of life care: Implications for further research.Journal of psychopharmacology (Oxford, England) · 2016-12-01Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The lancet. Psychiatry · 2016-07-01PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGThe international journal of neuropsychopharmacology · 2016-05-27PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportThe international journal of neuropsychopharmacology · 2016-05-27Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake RatsBiological ^|^ Pharmaceutical Bulletin · 2015-01-01The Use of Synthetic Cathinones and Tryptamines in a Psychiatric PopulationJournal of Forensic Toxicology and Pharmacology · 2013-01-01Moral transhumanism: the next step.The Journal of medicine and philosophy · 2012-08-01Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesiaSeeing and Perceiving · 2012-01-01Psilocybin slows binocular rivalry switching through serotonin modulationJournal of Vision · 2010-03-19Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptorsJournal of Vision · 2010-03-17The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicitySocial Neuroscience · 2003-01-01Synthesis of a psilocin hapten and a protein-hapten conjugateJournal of Pharmacy and Pharmacology · 2002-09-01Synthetic Studies of Psilocin Analogs Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.Chemical and Pharmaceutical Bulletin · 2002-01-01Analysis and Cultivation of Fruit Bodies and Mycelia of Psilocybe bohemicaBiochemie und Physiologie der Pflanzen · 1989-01-01